NCT06998433Phase 4Not yet recruiting
Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia
Effect of Platelet-Rich Plasma Versus Placebo in the Treatment of Central Centrifugal Cicatricial Alopecia: A Randomized Clinical Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Phase 4
- Sponsor
- Baylor College of Medicine
- Participants (registry)
- 56
- Start
- September 2025 (planned)
- Primary completion
- July 2026
- Study completion
- July 2026
- Last registry update
- September 2025
- Countries
- United States
Conditions studied: Central Centrifugal Cicatricial Alopecia
Interventions: Platelet-Rich Plasma (PRP) Injections, Saline
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.